Intrinsic Value of S&P & Nasdaq Contact Us

Prometheus Biosciences, Inc. RXDX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
36/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$138.57
-30.7%

Prometheus Biosciences, Inc. (RXDX) has 12 identified peers for comparison in the Healthcare sector. Peers include ACLX, AKRO, AMLX, APLS, BPMC, DAWN and others.

RXDX has a market capitalization of $9.56B, compared to an average peer market cap of $5.24B. RXDX is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message